No article found for “Armando Matteo”.

PF-04479745

☆ Save On Wikipedia ↗
PF-04479745
Clinical data
Other namesPF04479745; PF-4479745; PF4479745
Drug classSerotonin 5-HT2C receptor biased agonist; Serotonin 5-HT2A receptor antagonist; Serotonin 5-HT2B receptor antagonist
ATC code
  • None
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • (9S)-2-benzyl-N,9-dimethyl-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepin-4-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC17H22N4
Molar mass282.391 g·mol−1
3D model (JSmol)
  • C[C@H]1CNCCC2=C1N=C(N=C2NC)CC3=CC=CC=C3
  • InChI=1S/C17H22N4/c1-12-11-19-9-8-14-16(12)20-15(21-17(14)18-2)10-13-6-4-3-5-7-13/h3-7,12,19H,8-11H2,1-2H3,(H,18,20,21)/t12-/m0/s1
  • Key:IHHALLDEDARSAL-LBPRGKRZSA-N

PF-04479745 is a research ligand developed by Pfizer.[1] It is related to lorcaserin, and acts as a potent and selective agonist for the 5-HT2C receptor, with lower affinity and antagonist action at the related 5-HT2A and 5-HT2B receptor subtypes.[2]

See also

References

  1. "Delving into the Latest Updates on PF-4479745 with Synapse". Synapse. 24 January 2026. Retrieved 28 January 2026.
  2. Storer RI, Brennan PE, Brown AD, Bungay PJ, Conlon KM, Corbett MS, et al. (June 2014). "Multiparameter optimization in CNS drug discovery: design of pyrimido[4,5-d]azepines as potent 5-hydroxytryptamine 2C (5-HT2C) receptor agonists with exquisite functional selectivity over 5-HT2A and 5-HT2B receptors". Journal of Medicinal Chemistry. 57 (12): 5258–69. doi:10.1021/jm5003292. PMID 24878222.